COX7A2

COX7A2 (COXVIIa-L) is the ubiquitously expressed liver-type isoform of cytochrome c oxidase subunit VIIa, present across muscle and non-muscle tissues (PMID:1327965), and functions as the predominant structural component bridging Complex IV into respiratory chain supercomplexes: SILAC complexome profiling established that the majority of human respirasomes incorporate COX7A2 rather than COX7A2L/SCAFI, and these COX7A2-containing assemblies persist independently of SCAFI (PMID:33727070). Transcription of COX7A2 is governed by the mitochondrial biogenesis regulators NRF-1 and NRF-2 together with Sp1 acting on a compact proximal promoter (PMID:8567667), and in spermatogonia it is a direct target of E4F1, whose loss depletes the undifferentiated spermatogonial pool (PMID:37749649). Beyond its core role in oxidative phosphorylation, modulation of COX7A2 levels alters reactive oxygen species output at the respiratory chain: its overexpression in Leydig cells suppresses LH-induced testosterone synthesis by lowering StAR protein through ROS elevation (PMID:16752004), while its loss-of-function selectively triggers apoptosis in HIV-infected macrophages via enhanced ROS production at Complexes II and IV (PMID:34233649).

1. 1992 Medium

   Established the identity and tissue distribution of COX7A2 as a distinct cytochrome c oxidase subunit VIIa isoform, defining the gene whose mechanism would later be dissected.

   Evidence cDNA cloning, Northern/Southern blot, and chromosome mapping in human-rodent cell hybrids

   PMID:1327965

   Open questions at the time

   • Did not address how the isoform integrates into the holoenzyme or supercomplexes
   • Multiple mapped loci left genomic organization ambiguous
2. 1996 Medium

   Resolved how COX7A2 expression is controlled, linking the gene to the nuclear respiratory factor program that coordinates mitochondrial biogenesis.

   Evidence Promoter deletion/reporter assays and EMSA showing functional NRF-1, NRF-2, and Sp1 sites in a 92-bp proximal promoter

   PMID:8567667

   Open questions at the time

   • Did not test the promoter in tissue-specific contexts
   • Functional consequence of NRF binding on respiratory capacity not measured
3. 2006 Medium

   Connected COX7A2 levels to steroidogenic output, showing the subunit can act as a ROS-dependent suppressor of testosterone biosynthesis.

   Evidence Overexpression in TM3 Leydig cells with testosterone ELISA, StAR Western blot, and fluorometric ROS assay

   PMID:16752004

   Open questions at the time

   • Overexpression model only; loss-of-function effect on steroidogenesis untested
   • Causal chain from ROS to StAR suppression not directly demonstrated
4. 2011 Low

   Extended the steroidogenic mechanism by placing P70S6K signaling downstream of COX7A2 in the suppression of StAR.

   Evidence Overexpression in TM3 Leydig cells with phospho-P70S6K and StAR Western blots and testosterone ELISA

   PMID:21548202

   Open questions at the time

   • Single overexpression model with limited orthogonal validation in a lower-tier journal
   • Direct link between P70S6K phosphorylation and StAR levels not established
5. 2012 Low

   Probed whether COX7A2 subcellular localization is dynamically regulated, implicating Ras signaling in directing it away from mitochondria.

   Evidence EYFP fusion live-cell imaging with active and dominant-negative Ras in TM3 Leydig cells

   PMID:22898835

   Open questions at the time

   • Single imaging method with no biochemical confirmation of relocalization
   • Functional consequence of the localization change not tested
6. 2021 High

   Defined the core structural role of COX7A2 in respiratory chain organization, showing it, not SCAFI, is the predominant bridge of Complex IV into respirasomes.

   Evidence SILAC complexome profiling with CRISPR-Cas9 SCAFI knockout and native gel electrophoresis in HEK293T cells

   PMID:33727070

   Open questions at the time

   • Structural basis of the COX7A2-respirasome interface not resolved
   • Physiological consequence of COX7A2 loss on supercomplex assembly not tested
7. 2021 Medium

   Revealed a context-dependent vulnerability whereby loss of COX7A2 selectively kills HIV-infected cells through respiratory-chain ROS.

   Evidence Genome-wide shRNA screen with siRNA validation and Annexin-V flow cytometry in HIV-infected macrophages

   PMID:34233649

   Open questions at the time

   • Mechanism linking COX7A2 loss to Complex II/IV ROS not biochemically dissected
   • Why selectivity is restricted to infected cells unexplained
8. 2023 Medium

   Identified a tissue-specific transcriptional regulator, placing COX7A2 within an E4F1-driven respiratory gene program required for spermatogonial maintenance.

   Evidence Conditional E4F1 knockout mouse with scRNA-seq, ATAC-seq, and ChIP-seq promoter occupancy analysis

   PMID:37749649

   Open questions at the time

   • Did not isolate COX7A2's individual contribution to the spermatogonial phenotype
   • Direct functional rescue by COX7A2 not performed

• How COX7A2's role in respirasome bridging mechanistically connects to its ROS-modulating effects on steroidogenesis and infected-cell apoptosis remains unresolved.
• No structural model of COX7A2 within the respirasome
• Unclear whether ROS phenotypes stem from altered supercomplex assembly
• No loss-of-function study of COX7A2 in steroidogenic tissue